Promoting the Inclusion of Lung Volumes in the Reversibility Evaluation-Reply

Respir Care. 2017 Feb;62(2):256. doi: 10.4187/respcare.05411.

Authors

Conor T McCartney¹, Gregg L Ruppel², Ravi P Nayak²

Affiliations

¹ Department of Internal Medicine St. Louis University St. Louis, Missouri.
² Department of Internal Medicine Division of Pulmonary, Critical Care, and Sleep Medicine St. Louis University St. Louis, Missouri.

PMID: 28108693
DOI: 10.4187/respcare.05411

No abstract available

Publication types

Comment

MeSH terms

Bronchodilator Agents*
Humans
Lung*
Tidal Volume

Substances

Bronchodilator Agents